Forum Markets Management
Management criteria checks 0/4
Forum Markets' CEO is McAndrew Rudisill, appointed in Sep 2025, has a tenure of less than a year. total yearly compensation is $20.69M, comprised of 1% salary and 99% bonuses, including company stock and options. directly owns 0.077% of the company’s shares, worth $55.13K. The average tenure of the management team and the board of directors is 0.7 years and 0.9 years respectively.
Key information
McAndrew Rudisill
Chief executive officer
US$20.7m
Total compensation
| CEO salary percentage | 0.97% |
| CEO tenure | less than a year |
| CEO ownership | 0.08% |
| Management average tenure | less than a year |
| Board average tenure | less than a year |
Recent management updates
Recent updates
Ethereum Yield And Tokenized Assets Will Drive Future Forum Markets Upside
Catalysts About Forum Markets Forum Markets operates a technology platform that connects traditional finance with decentralized finance using Ethereum, combining ETH based yield generation with infrastructure for trading tokenized real world assets. What are the underlying business or industry changes driving this perspective?180 Life Sciences to raise $6.5M in direct stock offering
180 Life Sciences (NASDAQ:ATNF) stated Monday the company has signed a definitive $6.5M stock offering deal with a healthcare-focused U.S. institutional investor. The deal will include the issue of 6.13M common shares and warrants to purchase up to 6.13M additional share, at combined $1.06 per unit. Warrants have an exercise price of $1.06 per share with expiry of 5 years. The clinical-stage biotechnology said it intends to use the net proceeds for research and development expenses and general corporate purposes. Closing of the offering is expected on July 20, 2022. Stock is down 9% premarket, Monday, to trade at $1.04 vs. 52-week trading range of $0.80 to $9.05. Earlier: 180 Life Sciences falls after updates on regulatory path for anti-fibrosis therapy180 Life Sciences: Looking At Inflammation With Cannabis (Podcast)
180 Life Sciences' Prof. Sir Marc Feldmann, who co-founded ATNF with cannabis trailblazer Prof. Raphael Mechoulam, joins the podcast with Dr. Jonathan Rothbard, Chief Science Officer. Focusing on pain and inflammation space. Aiming for FDA approval. Human clinical trials. Limitations of bioavailability in CBD; advantages of synthetic CBD.What Type Of Shareholders Make Up 180 Life Sciences Corp.'s (NASDAQ:ATNF) Share Registry?
The big shareholder groups in 180 Life Sciences Corp. ( NASDAQ:ATNF ) have power over the company. Large companies...CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | -US$519m |
| Dec 31 2025 | US$21m | US$200k | -US$444m |
Compensation vs Market: McAndrew's total compensation ($USD20.69M) is above average for companies of similar size in the US market ($USD635.09K).
Compensation vs Earnings: Insufficient data to compare McAndrew's compensation with company performance.
CEO
McAndrew Rudisill (47 yo)
Mr. McAndrew Rudisill, BA (Econ), is Executive Chairman of Forum Markets, Incorporated (formerly known as ETHZilla Corporation) (formerly known as 180 Life Sciences Corp.) from July 2025 and serves as Chie...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman & CEO | less than a year | US$20.69m | 0.077% $ 55.1k | |
| Senior VP | less than a year | US$2.96m | 0.59% $ 418.2k | |
| Secretary | less than a year | US$242.16k | 0.0056% $ 4.0k | |
| Senior Vice President of Corporate Communications & Investor Relations | less than a year | no data | no data | |
| General Counsel | less than a year | no data | no data |
Experienced Management: FRMM's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman & CEO | less than a year | US$20.69m | 0.077% $ 55.1k | |
| Member of Scientific Advisory Board | 4.3yrs | no data | no data | |
| Independent Director | less than a year | US$18.39m | 0.39% $ 275.7k | |
| Member of Scientific Advisory Board | 4.3yrs | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | US$121.94k | 1.25% $ 890.0k | |
| Lead Independent Director | 2.3yrs | US$14.90m | 0% $ 0 | |
| Independent Director | less than a year | US$121.94k | 1.02% $ 725.7k | |
| Independent Director | less than a year | no data | no data | |
| Member of Scientific Advisory Board | 4.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 4.3yrs | no data | no data |
Experienced Board: FRMM's board of directors are not considered experienced ( 0.9 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/04 13:35 |
| End of Day Share Price | 2026/06/04 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Forum Markets, Incorporated is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mark Palmer | Benchmark Company |
| Jason McCarthy | Maxim Group |
| Nazibur Rahman | Maxim Group |